Nextar Chempharma Solutions Ltd.

www.nextar.co.il (under construction)

Formerly Aminolab Pharma

High-Tech Company

Acquired by Nextage

TECH VERTICALS

Biotechnology, Drug Delivery, Drug Development, Life Sciences, MedTech, Pharmaceuticals

General Data

Sector	Biomed
Company Stage:	Initial Revenues
Established	2007
Number of Employees	30
Reg. Number:	abCDe

DESCRIPTION

Nextar, a biotechnology company, develops and manufactures innovative pharmaceuticals and medical devices. With over 180 products brought to market as a CDMO and for its own portfolio, Nextar specializes in small-scale sterile and non-sterile manufacturing at certified facilities. The company is advancing its proprietary Brain-Transported Liposomes (BTLs) platform to deliver drugs across the blood-brain barrier, aiming to transform treatments for brain diseases like cancer and Parkinson's. Its first BTLs-based product is in development for glioblastoma treatment.

TECHNOLOGY

Brain Targeted Liposomes (BTLs) platform.

	TARGET MARKETS
	Biotech, Pharma, Medical Device firms.

	BUSINESS MODEL
	B2B

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Patent Attorneys
abC Defghij	Accounting Firm
abC Defghij	Law Firm

REMARKS

Date	Remark
06/03/2025	Nextar originally served as the parent company of Nextage Therapeutics. In Aug 2020 Nextage went public through a reverse merger with Micromedic. On March 6 2025 Nextar was acquired by Nextage and the two companies have merged under Nextage.

CONTACT INFO

Expand / Collapse All

Main Address: Ness Ziona, Israel

Address	13B Einstein St, Weizmann Science Park
City	Ness Ziona
Country	Israel
Zip	7403617

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Dr. Shimon Amselem	Founder	Marval Pharma (CSO)

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Mar. 06, 2025

Initial Revenues

abCDe

	PORTFOLIO COMPANIES

Exits (1)

Company Name		Exit Type	Date Announced	Amount	Remarks
abC Defghij		Holdings Sold	06/03/2025	abCDe

Last Updated:	abCDe
IVC Number:	abCDe